Megan D. Bailey - 05 May 2023 Form 4 Insider Report for LABORATORY CORP OF AMERICA HOLDINGS (LH)

Role: EVP, Chief Strategy Officer
Signature: /s/ Sandra D. van der Vaart, Attorney-in-Fact for Megan D. Bailey
Issuer symbol: LH
Transactions as of: 05 May 2023
Net transactions value: $0
Form type: 4
Filing time: 09 May 2023, 16:43:15 UTC
Previous filing: 08 May 2023
Next filing: 08 Feb 2024
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	LH	Restricted Stock Unit	Award	$0	+180	+3.9%	$0.000000	4,807	05 May 2023	Common Stock	180		Direct	F1, F2, F3
transaction	LH	Non-qualified Stock Options	Award	$0	+600		$0.000000	600	05 May 2023	Common Stock	600	$223.86	Direct	F4, F5

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock.
F2	The Restricted Stock Units vest in three equal annual installments beginning on February 7, 2024.
F3	This number reflects the aggregate number of Restricted Stock Units held by the reporting person.
F4	Employee stock option (right to buy) granted pursuant to the Laboratory Corporation of America Holdings 2016 Omnibus Incentive Plan.
F5	The option vests in three equal annual installments beginning on the date reflected in this column.